You are here: Industry Insights > TB

News List

WHO Prequalifies Ethionamide for Indian firm SHEM OIRERE
May 04, 2023
The World Health Organization (WHO) in early April 2023 pre-qualified ethionamide, manufactured by Indian pharmaceutical company, Micro Labs Limited.
Trial reveals BPaL regimen for highly drug-resistant TB is effective even with reduced dose of linezolid expresspharma
July 16, 2021
This regimen reduces the treatment time for highly drug-resistant forms of TB from 18 months or longer to a six-month duration.
Zendal and IAVI Partner for TB Vaccine Candidate americanpharmaceuticalreview
July 15, 2021
Biofabri and IAVI announced their intention to partner on efficacy trials of tuberculosis (TB) vaccine candidate, MTBVAC.
VinBrain and FIT Jointly Release a White Paper on Utilizing Artificial Intelligence in Tuberculosis Screening prnasia
June 11, 2021
On June 10, 2021, VinBrain (Vingroup) and FIT (a German NGO working in the field of Tuberculosis prevention and control) jointly release a white paper on utilizing artificial intelligence (AI) in Tuberculosis (TB) diagnosis and screening in Vietnam.
CGTN: Peng Liyuan calls for global efforts in AIDS and TB prevention and treatment prnasia
June 08, 2021
Peng Liyuan, wife of Chinese President Xi Jinping, called on people from all walks of life in all countries to join hands and take action to strengthen the prevention and treatment of AIDS and tuberculosis (TB), in order to benefit all mankind and ...
BATM Develops Molecular Diagnostics Test for Tuberculosis americanpharmaceuticalreview
March 30, 2021
BATM has developed a new method for the rapid and comprehensive diagnosis of tuberculosis (TB). The testing and validation phase, which is expected to commence in the second half of this year, will be fully funded under a program of the Stop TB ...
BCG vaccine protects newborns against a variety of infectious diseases, finds study europeanpharmaceuticalreview
February 20, 2021
According to researchers, ensuring that newborns in areas with high rates of infectious disease receive the BCG vaccine at birth, could have a major impact on infections and deaths.
One of the oldest vaccines could help combat COVID-19 europeanpharmaceuticalreview
November 26, 2020
Researchers have shown that recipients of the Bacillus Calmette-Guérin (BCG) vaccine are less likely to contract COVID-19 in a new study.
UK to commence anti-TB BCG vaccine trials to test efficacy against COVID-19 expresspharma
October 14, 2020
Previous studies suggest that the BCG vaccine could reduce susceptibility to a range of infections caused by viruses including those similar to the novel coronavirus causing COVID-19.
New Rapid Molecular Test for Tuberculosis Released americanpharmaceuticalreview
July 24, 2020
The Foundation for Innovative New Diagnostics (FIND) and Cepheid announced the launch of the new Xpert® MTB/XDR test, which enables expanded drug-resistance tuberculosis (TB) profiling in less than 90 minutes.

Previous page 1 2 3 4 5 Next page